MINERVA S.A.

Publicly-Held Company

CNPJ No. 67.620.377/0001-14

NIRE 35.300.344.022 - CVM Code No. 02093-1

NOTICE TO SHAREHOLDERS

Minerva S.A. ("Minerva" or "Company") hereby informs its shareholder that the Company's Board of Directors, on September 13th, 2018, approved the Company's capital increase, within the limit of the authorized capital provided for in Article 6 of the Company's Bylaws, through the private subscription of new shares, as a result of the exercise, by certain beneficiaries, of their respective stock options, granted under the First Stock Option Program approved at the Meeting of the Company's Board of Directors held on March 5th, 2018 and amended at the Meeting of the Company's Board of Directors held on June 25th, 2018 ("First Program"), which integrates the Second Stock Option Plan of the Company, approved at the Extraordinary Shareholders' Meeting held on April 12th, 2017 ("Stock Option Plan"). In view of such approval, the following information is hereby provided with respect to the capital increase of the Company, pursuant to Annex 30-XXXII to CVM Instruction 480, dated December 7th, 2009, as amended:

REPORTING ON CAPITAL INCREASE RESOLVED BY THE BOARD OF DIRECTORS

Article 1. The issuer must disclose to the market the amount of the increase and the new capital, and whether the increase will be made through:

  • I - conversion of debentures or other debt securities into shares;

  • II - exercise of right of subscription or subscription bonus;

  • III - capitalization of profits or reserves; or

  • IV - subscription of new shares.

Sole paragraph. The issuer must also:

I - explain, in detail, the reasons for the increase and its legal and economic consequences; and

II - provide a copy of the opinion of the fiscal council, if applicable.

Not applicable since the capital increase is based solely on the exercise, by certain beneficiaries, of their respective stock options, granted under the First Program, which integrates the Stock Option Plan of the Company.

Article 2. In case of capital increase through subscription of shares, the issuer must:

  • I - describe the allocation of resources;

  • II - inform the number of issued shares of each type and class;

  • III - describe the rights, advantages and restrictions attributed to the shares to be issued;

  • IV - inform if related parties, as defined by the accounting rules that deal with this subject, will subscribe shares in the capital increase, specifying the respective amounts, when those amounts are already known;

  • V - inform the issue price of the new shares;

  • VI - inform the nominal value of the issued shares or, in case of shares without par value, the portion of the issue price that will be allocated to the capital reserve;

VII - provide management's opinion on the effects of the capital increase, especially with regard to the dilution caused by the increase;

VIII - inform the calculation criteria of the issue price and justify, in detail, the economic aspects that determined its choice;

IX - if the issue price was set with premium or discount in relation to the market value, identify the reason for the premium or discount and explain how it was determined;

  • X - provide a copy of all reports and studies that subsidized the issue price;

  • XI - to inform the quotation of each of the types and classes of shares of the issuer in the markets in which they are traded, identifying:

  • a) minimum, average and maximum quotation of each year, in the last 3 (three) years;

  • b) minimum, average and maximum quotation of each quarter, in the last 2 (two) years;

  • c) minimum, average and maximum quotation of each month, in the last 6 (six) months; and d) average quotation in the last 90 (ninety) days;

  • XII - inform the issue prices of shares in capital increases made in the last 3 (three) years;

  • XIII - present the percentage of potential dilution resulting from the issue;

  • XIV - inform the terms, conditions and form of subscription and payment of issued shares;

  • XV - inform if the shareholders will have preemptive rights to subscribe to the new shares issued and to detail the terms and conditions to which this right is subject;

  • XVI - inform the management proposal for the treatment of any leftovers;

  • XVII - describe, in detail, the procedures to be adopted, if there is provision for partial homologation of the capital increase; and

XVIII - if the issue price of the shares can be, totally or partially, in assets:

  • a) present a complete description of the assets that will be accepted;

  • b) clarify the relationship between the assets and their corporate purpose; and

  • c) provide a copy of the valuation report of the assets, if available.

Not applicable since the capital increase is based solely on the exercise, by certain beneficiaries, of their respective stock options, granted under the First Program, which integrates the Stock Option Plan of the Company.

Article 3. In case of capital increase through capitalization of profits or reserves, the issuer must:

I - inform whether it will imply a change in the par value of the shares, if any, or distribution of new shares among the shareholders;

II - state whether the capitalization of profits or reserves will be effected with or without modification of the number of shares, in companies with shares with no par value;

III - in case of distribution of new shares:

  • a) inform the number of issued shares of each type and class;

  • b) inform the percentage that the shareholders will receive in shares;

  • c) describe the rights, advantages and restrictions attributed to the shares to be issued;

  • d) inform the cost of acquisition, in reais per share, to be allocated so that the shareholders can comply with art. 10 of Law 9,249, of December 26, 1995; and e) inform the treatment of fractions, if applicable;

  • IV - inform the period provided for in § 3 of art. 169 of Law 6404, of 1976; and

  • V - inform and provide the information and documents provided for in article 2 above when applicable.

Not applicable since the capital increase is based solely on the exercise, by certain beneficiaries, of their respective stock options, granted under the First Program, which integrates the Stock Option Plan of the Company.

Article 4. In case of capital increase by conversion of debentures or other debt securities into shares or by exercise of subscription warrants, the issuer must:

  • I - inform the number of issued shares of each type and class; and

  • II - describe the rights, advantages and restrictions attributed to the shares to be issued.

Not applicable since the capital increase is based solely on the exercise, by certain beneficiaries, of their respective stock options, granted under the First Program, which integrates the Stock Option Plan of the Company.

Article 5. The provisions of articles 1 to 4 of this Annex does not apply to capital increases resulting from an option plan, in which case the issuer must report:

I - date of the shareholders' general meeting in which the option plan was approved;

The Stock Option Plan of the Company was approved at the Extraordinary Shareholders'

Meeting held on April 12th, 2017.The First Program, which integrates the Stock Option Plan of the Company, was approved at the Meeting of the Company's Board of Directors held on March 5th, 2018 and amended at the Meeting of the Company's Board of Directors held on June 25th, 2018.

II - amount of capital increase and new capital stock;

The capital increase resulting of the exercise, by certain beneficiaries, of their respective stock options, granted under the First Program, was in the total amount of R$ 15.680.000,00 (fifteen million, six hundred and eighty thousand reais), so that the Company's capital increased from the current R$ 134.751.823,37 one hundred and thirty-four million, seven hundred and fifty-one thousand, eight hundred and twenty-threeBrazilian Reais and thirty-seven cents, divided into 223.618.459 two hundred and twenty-three million, six hundred and eighteen thousand, four hundred and fifty-nine common shares, all nominative, book-entry shares with no par value, to R$ 150.431.823,37 (one hundred and fifty million, four hundred and thirty-one thousand, eight hundred and twenty-three Reais and thirty-seven cents), divided into 226.418.459 (two hundred and twenty six million, four hundred and eighteen thousand, four hundred and fifty nine) common shares, all nominative, book-entry shares with no par value.

III - number of issued shares of each type and class;

A total of 2.800.000 (two million and eight hundred thousand) common shares, all nominative, book-entry shares with no par value were issued, resulting of the exercise, by certain beneficiaries, of their respective stock options, granted under the First Program.

IV - issue price of new shares;

The issue price of the new common shares, all nominative, book-entry shares with no par value issued resulting of the exercise, by certain beneficiaries, of their respective stock options, granted under the First Program, is R$ 5,60 (five reais and sixty cents) per share.

V - price of each types and classes of shares of the issuer in the markets in which they are traded, identifying:

a) minimum, average and maximum quotation of each year, in the last 3 (three)

years;

2017

2016

2015

Average

R$11.31

R$10.50

R$10.46

Maximum

R$12.97

R$12.94

R$13.76

Minimum

R$9.34

R$8.75

R$7.16

b) minimum, average and maximum quotation of each quarter, in the last 2 (two)

years;

4T17

3T17

2T17

1T17

4T16

3T16

2T16

1T16

Average

R$11.14

R$12.15

$10.72

$11.20

R$11.01

R$9.42

R$9.92

R$11.74

Maximum

R$11.85

$12.97

R$12.31

R$12.19

R$12.40

R$10.10

R$11.37

R$12.94

Minimum

R$10.19

R$10.97

R$9.45

R$9.34

R$9.49

R$8.83

R$8.75

R$11.19

c) minimum, average and maximum quotation of each month, in the last 6 (six) months; and

Aug/2018

Jul/2018

Jun/2018

May/2018

Apr/2018

Mar/2018

Average

R$6.49

R$7.03

R$7.01

R$7.39

R$8.14

R$8.44

Maximum

R$7.51

R$7.54

R$8.00

R$8.00

R$8.47

R$9.34

Minimum

R$5.82

R$6.44

R$6.27

R$6.95

R$7.45

R$7.57

d) average quotation in the last 90 (ninety) days;

Average last ninety (90) days

R$6.57

VI - percentage of potential dilution resulting from the issue.

The issue resulting from the capital increase will cause a dilution of 1.236648289%.

Barretos, September 13th, 2018.

Eduardo Pirani Puzziello

Investor Relations Officer

Attachments

  • Original document
  • Permalink

Disclaimer

Minerva SA published this content on 13 September 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 September 2018 22:12:02 UTC